Meeting Details
The 27th Annual General Meeting of Sai Life Sciences Limited was held on Thursday, September 17, 2026, at 10:30 A.M. (IST) through Video Conferencing (VC) / Other Audio Visual Means (OAVM).
Attendance
Directors Present:
- Dr. Kanumuri Ranga Raju, Chairman & Whole Time Director
- Mr. Krishnam Raju Kanumuri, Managing Director & Chief Executive Officer
- Mr. Sivaramakrishnan Chittor, Whole-time Director & Chief Financial Officer
- Mr. Dinesh Vinoobhai Patel, Independent Director
- Mr. Ramesh Ganesh Iyer, Independent Director
- Ms. Suchita Sharma, Independent Director
In Attendance:
- Ms. Runa Karan, Company Secretary & Compliance Officer
- Ms. Madhavi Kalva, Representative of Statutory Auditors
- Mr. DS Rao, Representative of Secretarial Auditors
- Mr. DSM Ram, Scrutinizer of the Meeting
94 members holding 7,76,98,047 equity shares attended the meeting through VC/OAVM.
Meeting Proceedings
The Company Secretary welcomed members and confirmed the meeting was conducted in compliance with MCA and SEBI circulars. The Notice of the 27th AGM together with the Integrated Annual Report for FY 2025-2026 had been sent electronically to members with registered email IDs, and via QR code letters to others.
Members were informed that there were no qualifications, observations, or adverse comments in both the Auditor's Report and Secretarial Audit Report.
Various registers including Register of Directors' and KMP Shareholding (Section 170 of Companies Act, 2013), Register of contracts (Section 189), and Compliance Certificate (Regulation 13 of SEBI Share Based Employee Benefits Regulations, 2021) were available for electronic inspection during the meeting.
Voting Process
The company provided e-voting facilities through KFin Technologies Limited. Remote e-voting was open from 9:00 A.M. (IST) on September 14, 2026, to 5:00 P.M. (IST) on September 16, 2026. Mr. DSM Ram, Practising Company Secretary, was appointed as Scrutinizer. Members who had voted remotely could participate but not vote again during the AGM.
Management Presentation
Due to a technical issue, Mr. Sivaramakrishnan Chittor, Whole-Time Director & CFO, presented on behalf of Mr. Krishnam Raju Kanumuri, MD & CEO. The presentation included a detailed overview of the company's financial performance for FY 2025-26, highlighting key financial and operational achievements, growth strategy, business outlook, and future opportunities for sustainable growth and value creation.
Shareholder Interaction
Pre-registered speaker shareholders were given opportunity to offer comments and seek clarifications. Mr. Krishnam Raju Kanumuri, MD & CEO, addressed all queries and provided clarifications.
Business Transacted
Ordinary Business:
1. To receive, consider and adopt the Audited Standalone Financial Statements for the year ended March 31, 2026, together with reports of Board of Directors and auditors, and the Audited Consolidated Financial Statements for the year ended March 31, 2026 with auditor's report.
2. To appoint a director in place of Mr. Krishnamraju Kanumuri (DIN: 00064614), who retires by rotation and offered himself for re-appointment.
Voting Conclusion and Results
Shareholders present at the meeting who had not voted prior could vote within 15 minutes of conclusion. The Scrutinizer will submit his e-voting report within two working days to the Chairman. Results will be declared and disclosed to NSE and BSE, and hosted on the company's website (https://sailife.com/annual-reports/) and Kfin's website.
All resolutions, if passed with requisite majority, are deemed passed on September 17, 2026.
Meeting Conclusion
The meeting concluded at 11:25 A.M. (IST).